Kenneth B. Kassler-Taub - Feb 28, 2024 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
SVP, Regulatory & QA
Signature
/s/ Kenneth B. Kassler-Taub, M.D.
Stock symbol
LXRX
Transactions as of
Feb 28, 2024
Transactions value $
-$63,805
Form type
4
Date filed
2/29/2024, 04:29 PM
Previous filing
Feb 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +7.09K +5.92% 127K Feb 28, 2024 Direct F1
transaction LXRX Common Stock Options Exercise +27.6K +21.75% 154K Feb 28, 2024 Direct F1
transaction LXRX Common Stock Options Exercise +32.8K +21.23% 187K Feb 28, 2024 Direct F1
transaction LXRX Common Stock Tax liability -$63.8K -24.4K -13.02% $2.62 163K Feb 28, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -7.09K -100% 0 Feb 28, 2024 Common Stock 7.09K Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -27.6K -50% 27.6K Feb 28, 2024 Common Stock 27.6K Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -32.8K -33.33% 65.5K Feb 28, 2024 Common Stock 32.8K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.